DUBLIN--(BUSINESS WIRE)-- ICON plc (ICLR), (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024.
Icon reported over $2 billion in revenue in the third quarter, up 1.3% from the prior-year period. Adjusted EBITDA was nearly $397 million in the quarter, or 19.4% of revenue. Management raised its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback